ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Rheumatology Network

Focus on Axial Spondyloarthritis

In this series of stories we focus on highlighting common axSpA manifestations, compare treatment recommendations and summarize the newly condensed ASAS-EULAR treatment recommendations. (©Illustrart/Shutterstock.com)

 

 

Recent Content

(©DmitryKalinovsky/Shutterstock.com)

In this slideshow, we offer a glance at newly approved treatments for rheumatoid arthritis, juvenile arthritis, osteoporosis and fingernail psoriasis, among other conditions.

@Lightspring/Shutterstock.com)

Chronic back pain, arthritis and enthesitis are among common axSpA manifestations, but no two patients are alike. Here, we highlight key presentations.

(©bleakstar/Shuttersstock.com)

EULAR-ASAS have updated the 2010 guidelines for axSpA emphasizing treat to target, tapering and for the first time, cost considerations.

Back Pain (©Lightspring/Shutterstock.com)

In this slideshow, we highlight the 13 ASAS-EULAR treatment management guidelines for axial spondyloarthritis.

(©JPC-PROD/Shutterstock.com)

Early stage RA treated with tocilizumab or tocilizumab and methotrexate realized clinical benefits with no safety concerns at two years.

(©FamVeld/Shutterstock.com)

Research shows that for women with autoimmune disease, the increase risk of infection during pregnancy is associated with steroids, not DMARDs.

(©PuwadolJaturawutthichai/Shutterstock.com)

Estimates for juvenile idiopathic arthritis differ widely depending on which set of criteria doctors use.

By clicking Accept, you agree to become a member of the UBM Medica Community.